Kenneth Schooley

4.3k total citations · 1 hit paper
12 papers, 3.6k citations indexed

About

Kenneth Schooley is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kenneth Schooley has authored 12 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Kenneth Schooley's work include Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and T-cell and B-cell Immunology (3 papers). Kenneth Schooley is often cited by papers focused on Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and T-cell and B-cell Immunology (3 papers). Kenneth Schooley collaborates with scholars based in United States, Canada and United Kingdom. Kenneth Schooley's co-authors include Jennifer L. Slack, Roy A. Black, Douglas Pat Cerretti, Beverly J. Castner, Jacques J. Peschon, Carl J. March, Norman Boiani, Nicole Nelson, Martin F. Wolfson and Raymond J. Paxton and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Blood.

In The Last Decade

Kenneth Schooley

12 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

1997 2.6k citations Roy A. Black, Charles T. Rauch et al. Nature profile →

Peers

Countries citing papers authored by Kenneth Schooley

Since Specialization

Citations

This map shows the geographic impact of Kenneth Schooley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Schooley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Schooley more than expected).

Fields of papers citing papers by Kenneth Schooley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Schooley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Schooley. The network helps show where Kenneth Schooley may publish in the future.

Co-authorship network of co-authors of Kenneth Schooley

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Schooley. A scholar is included among the top collaborators of Kenneth Schooley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Schooley. Kenneth Schooley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency 2024 ·Journal of Pharmacology and Experimental Therapeutics ·Pamela J. Smolak, MyTrang Nguyen, (unknown), (unknown), John R. Doedens, Kenneth Schooley, John N. Snouwaert, Mark G. Bock, David Harrison, Alan P. Watt, Beverly H. Koller, Christopher A. Gabel	9
2	Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders 2023 ·Journal of Medicinal Chemistry ·David Harrison, Andy Billinton, Mark G. Bock, John R. Doedens, Christopher A. Gabel, M. Katharine Holloway, Roderick A. Porter, Valérie Reader, (unknown), Kenneth Schooley, Alan P. Watt	35
3	505 TIMP-3 BINDS DIRECTLY TO THE LRP-1 SCAVENGER RECEPTOR, AND BLOCKING THIS INTERACTION PROMOTES TIMP-3 ACCUMULATION 2009 ·Osteoarthritis and Cartilage ·(unknown), Annette Bakker, (unknown), (unknown), (unknown), (unknown), Kenneth Schooley, Salvatore Catania, Deborah H. Strickland, Roy A. Black	1
4	Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level 2003 ·Biochemical Journal ·Kenneth Schooley, Ping Zhu, Steven Dower, Eva E. Qwarnström	25
5	UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells 2002 ·The Journal of Immunology ·Claire L. Sutherland, N. Jan Chalupny, Kenneth Schooley, Tim VandenBos, Marek Kubin, David Cosman	211
6	Identification of Two Major Sites in the Type I Interleukin-1 Receptor Cytoplasmic Region Responsible for Coupling to Pro-inflammatory Signaling Pathways 2000 ·Journal of Biological Chemistry ·Jennifer L. Slack, Kenneth Schooley, Timothy P. Bonnert, Jennifer L. Mitcham, Eva E. Qwarnström, John E. Sims, Steven Dower	271
7	Effect of PDI Overexpression on Recombinant Protein Secretion in CHO Cells 2000 ·Biotechnology Progress ·Roger J. Davis, Kenneth Schooley, Brian Schou Rasmussen, James N. Thomas, Prasad Reddy	89
8	A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells breakdown → 1997 ·Nature ·Roy A. Black, Charles T. Rauch, Carl J. Kozlosky, Jacques J. Peschon, Jennifer L. Slack, Martin F. Wolfson, Beverly J. Castner, Kim L. Stocking, P. Linga Reddy, (unknown), Nicole Nelson, Norman Boiani, Kenneth Schooley, Mary Gerhart, Raymond Davis, Jeffrey N. Fitzner, Richard S. Johnson, Raymond J. Paxton, Carl J. March, Douglas Pat Cerretti	2557
9	Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit 1997 ·Journal of Biological Chemistry ·Timothy A. Bird, Kenneth Schooley, Steven Dower, (unknown), G. Duke Virca	188
10	Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently 1995 ·Blood ·Satoru Kumaki, HD Ochs, (unknown), Kenneth Schooley, Minoo Ahdieh, Helene Z. Hill, Kazuo Sugamura, Dirk Anderson, Qili Zhu, David Cosman	29
11	Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. 1993 ·Journal of Biological Chemistry ·Jennifer L. Slack, Catherine J. McMahan, Sheela Waugh, Kenneth Schooley, Melanie K. Spriggs, John E. Sims, Steven Dower	91
12	IL-1 induces rapid phosphorylation of the IL-1 receptor. 1989 ·The Journal of Immunology ·Byron Gallis, K S Prickett, Jana L. Jackson, Jennifer L. Slack, Kenneth Schooley, John E. Sims, Steven Dower	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact